Evolent Health (EVH) Reports In-Line Q2 EPS

Evolent Health (NYSE: EVH) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $107.3 million versus the consensus estimate of $104.45 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank